Research Article
ROS-Mediated Mitochondrial Pathway is Required for Manilkara Zapota (L.) P. Royen Leaf Methanol Extract Inducing Apoptosis in the Modulation of Caspase Activation and EGFR/NF-κB Activities of HeLa Human Cervical Cancer Cells
Table 2
Treatment of Manilkara zapota leaf methanol extract (1.56-200 μg/mL) on selected cancer cell lines for 24, 48, and 72 h evaluated by MTT and LDH assays.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HCT-116: human colon carcinoma, HeLa: human cervical cancer, HepG2: human hepatocellular carcinoma, HGT-1: human gastric adenocarcinoma, HT-29: human colorectal adenocarcinoma, LDH: lactate dehydrogenase, and MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Values are reported as mean ± SD (n = 3). Value with different superscript letter in the same row for their respective assay indicates significant difference by Tukey’s test (P < 0.05). In MTT assay, treatment with Manilkara zapota leaf methanol extract for 72 h (69.12 ± 8.10 μg/mL) significantly inhibited the proliferation of HT-29 cells compared to 24 h (93.27 ± 17.19 μg/mL) (P < 0.05), whereas, in LDH assay, there was a significant effect of the cytotoxic activities of Manilkara zapota leaf methanol extract in HT-29 cells incubated for 72 h (76.22 ± 5.39 μg/mL) compared to those incubated for 24 h (90.33 ± 15.79 μg/mL) or 48 h (85.99 ± 4.87 μg/mL) (P < 0.05). |